Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FX1ZZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,995
Award facts
- Contract value 100% obligated
- $24,995.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25K to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois facility. This delivery order is issued under the company's larger Indefinite Delivery Contract with the DLA valued at $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
As a specialized pharmaceutical wholesaler registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's contract portfolio with DLA demonstrates its capability to supply diverse pharmaceutical products ranging from contraceptive devices to oncology treatments and vaccines. This particular delivery order for Nexplanon implants supports the medical supply needs of Department of Defense healthcare systems and reflects the company's ongoing role in providing essential pharmaceutical products to federal agencies.
Quick answers
Who was awarded contract SPE2DB25FX1ZZ?
SPE2DB25FX1ZZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FX1ZZ worth?
The government has obligated $24,995 on SPE2DB25FX1ZZ.
Is contract SPE2DB25FX1ZZ an order under another contract?
Yes. SPE2DB25FX1ZZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1ZZ competed?
The extent of competition for SPE2DB25FX1ZZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award